1. ？Murray CJ,Lopez AD.Alternative projections of mortality and disability by cause 1990-2020:Global Burden of Disease Study. Lancet,1997,349:1498-1504.
[2]
3. Iyer AS,Wells JM,Vishin S,et al. CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD.Chest,2014,145:824-832.
[3]
16. Sims MW,Margolis DJ,Localio AR,et al. Impact of pulmonary artery pressure on exercise function in severe COPD. Chest,2009,136:412-419.
[4]
18. Parola D,Romani S,Petroianni A,et al. Treatment of acute exacerbations with non-invasive ventilation in chronic hypercapnic COPD patients with pulmonary hypertension. Eur Rev Med Pharmacol Sci,2012,16:183-191.
[5]
19. Minai OA,Chaouat A,Adnot S. Pulmonary hypertension in COPD:epidemiology,significance,and management pulmonary vascular disease:the global perspective. Chest,2010,137(6 Suppl):39S-51S.
[6]
20. Hoeper MM,Lee SH,Voswinckel R,et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol,2006,48:2546-2552.
[7]
21. Hill NS,Klinger JR,Warburton RR,et al. Brain natriuretic peptide:possible role in the modulation of hypoxic pulmonary hypertension.Am J Physiol,1994,266:308-315.
[8]
22. Inoue Y,Kawayama T,Iwanaga T,et al. High plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or cor pulmonale. Intern Med,2009,48:503-512.
9. Wells JM,Washko GR,Han MK,et al. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med,2012,367:913-921.
[18]
15. Jensen HH,Godtfredsen NS,Lange P,et al. Potential misclassification of causes of death from COPD. Eur Respir J,2006,28:781-785.
[19]
17. Kessler R,Faller M,Fourgaut G,et al. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med,1999,159:158-164.
[20]
23. Sormunen P,Kallio MJ,Kili IT,et al.C-reactive protein is useful in distinguishing Gram stain negative bacterial meningitis from viral meningitis in children.Pediater,1999,134:725-729.
[21]
26. Humbert M,Monti G,Brenot F,et al.Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.Am J Respir Crit Care,1995,151:1628-1631.
[22]
2. Ng CS,Wells AU,Padley SP. A CT sign of chronic pulmonary arterial hypertension:the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging,1999,14:270-278.
12. Committee GS. Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease (updated 2013). www.goldcopd.org.
[28]
13. Buist AS,McBurnie MA,Vollmer WM,et al. International variation in the prevalence of COPD (the BOLD Study):a population-based prevalence study.Lancet,2007,370:741-750.
[29]
14. Zhong N,Wang C,Yao W,et al. Prevalence of chronic obstructive pulmonary disease in China:a large,population-based survey. Am J Respir Crit Care Med,2007,176:753-760.
